首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Comparative study of efficacy and safety of intravenous ferric carboxy maltose versus iron sucrose in treatment of postpartum iron deficiency anemia
【24h】

Comparative study of efficacy and safety of intravenous ferric carboxy maltose versus iron sucrose in treatment of postpartum iron deficiency anemia

机译:静脉内羧化麦芽糖铁与蔗糖铁治疗产后缺铁性贫血的疗效和安全性比较研究

获取原文
           

摘要

Background: Iron deficiency is the commonest treatable cause of postpartum anemia. Parenteral iron therapy results faster and higher replenishment of iron stores and correction of Hb levels with better compliance. The study was to compare the safety and efficacy of ferric carboxy maltose (FCM) with iron sucrose to treat iron deficiency anemia in the post-partum. Methods: 200 women of postpartum iron deficiency anemia were allocated into two groups. Iron sucrose group, subjects were given I.V. iron sucrose in multiple doses, 200 mg/day on day 0,2,4,6,8 total of 1000 mg. FCM group , subjects were given I.V. ferric carboxymaltose 1000 mg single dose. Both groups Hb%, and serum ferritin were done on 0 and day 30 of last dose of parenteral iron. Side effects, compliance were noted. Results: There was statistically significant rise (P
机译:背景:缺铁是可治疗的产后贫血的最常见原因。肠胃外铁疗法可以更快,更高地补充铁,并以更好的依从性纠正Hb水平。该研究旨在比较羧基麦芽糖(FCM)和蔗糖铁治疗产后缺铁性贫血的安全性和有效性。方法:将200名产后缺铁性贫血妇女分为两组。蔗糖铁组,受试者进行静脉注射。多剂量蔗糖铁,第0、2、4、6、8天共200毫克/天,共1000毫克。 FCM组,受试者接受静脉注射。羧基麦芽糖铁1000毫克单剂。两组Hb%和血清铁蛋白均在非肠道铁剂最后剂量的第0天和第30天进行。注意到副作用,依从性。结果:有统计学意义的上升(P

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号